362 related articles for article (PubMed ID: 24238488)
1. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
[TBL] [Abstract][Full Text] [Related]
2. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
[TBL] [Abstract][Full Text] [Related]
3. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
4. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention.
Oduncu V; Erkol A; Karabay CY; Şengül C; Tanalp AC; Fotbolcu H; Özveren O; Bitigen A; Pala S; Kırma C
Int J Cardiol; 2013 Oct; 168(4):3480-5. PubMed ID: 23688433
[TBL] [Abstract][Full Text] [Related]
5. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.
Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D
Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846
[TBL] [Abstract][Full Text] [Related]
6. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Elbasan Z; Şahin DY; Gür M; Kuloğlu O; Kivrak A; Içen YK; Türkoglu C; Yildirim A; Özdogru I; Çayli M
Angiology; 2014 Jan; 65(1):37-42. PubMed ID: 23109331
[TBL] [Abstract][Full Text] [Related]
7. Uric Acid is a Useful Tool to Predict Contrast-Induced Nephropathy.
Mendi MA; Afsar B; Oksuz F; Turak O; Yayla C; Ozcan F; Johnson RJ; Kanbay M
Angiology; 2017 Aug; 68(7):627-632. PubMed ID: 27006404
[TBL] [Abstract][Full Text] [Related]
8. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
9. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
10. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
[TBL] [Abstract][Full Text] [Related]
11. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
[TBL] [Abstract][Full Text] [Related]
13. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
[TBL] [Abstract][Full Text] [Related]
14. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
15. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
16. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
[TBL] [Abstract][Full Text] [Related]
17. Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
Leone AM; De Caterina AR; Sciahbasi A; Aurelio A; Basile E; Porto I; Trani C; Burzotta F; Niccoli G; Mongiardo R; Mazzari MA; Buffon A; Panocchia N; Romagnoli E; Lioy E; Rebuzzi AG; Crea F
EuroIntervention; 2012 Nov; 8(7):839-47. PubMed ID: 23171803
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
[TBL] [Abstract][Full Text] [Related]
19. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
